Table 2.
Primary motor, cognitive and functional outcomes for the EDNA treatment and GRASP control groups at pre-test, post-test and follow-up
| Primary outcomea | EDNA treatment (n = 10) | GRASP control (n = 7) | Group effect on pre-post change score (t, p)c | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-test | Post-test | Follow-up | Pre-post Change scoreb | Effect sized | Pre-test | Post-test | Follow-up | Pre-post change scoreb | Effect sized | ||
| Motor | |||||||||||
| BBT-MAH | 23.5 (9.6) | 34.7 (13.8) | 35.5 (12.8) |
11.2 (9.8) p = 0.006* |
0.90 | 15.7 (10.8) |
16.0 (9.4) |
17.9 (8.1) |
− 0.3 (9.9) p = 0.942 |
0.03 | t = 2.25, p = 0.040* |
| BBT-LAH | 41.2 (14.4) | 46.9 (10.9) | 48.8 (12.5) |
5.7 (13.2) p = 0.205 |
0.43 | 36.6 (10.8) |
36.0 (12.5) |
38.4 (9.7) |
0.6 (7.8) p = 0.853 |
0.05 | t = 1.12, p = 0.280 |
| 9HPT-MAH | 0.21 (0.20) | 0.34 (0.25) |
0.13 (0.20) p = 0.072 |
0.55 | 0.08 (0.14) |
0.14 (0.13) |
0.06 (0.11) p = 0.219 |
0.42 | t = 0.97, p = 0.348 | ||
| 9HPT-LAH | 0.58 (0.27) | 0.59 (0.25) |
0.01 (0.24) p = 0.989 |
0.04 | 0.48 (0.15) |
0.49 (0.08) |
0.01 (0.01) p = 0.840 |
0.08 | t = -0.10, p = 0.922 | ||
| Cognitive | |||||||||||
| MoCA | 18.5 (5.1) | 21.9 (4.1) | 23.0 (5.0) | 3.4 (3.0) p = .006* | 0.70 | 17.0 (7.8) | 18.7 (6.0) | 21.1 (5.6) | 0.1 (3.2) p = 0.911 | 0.23 | t = 2.31, p = 0.036* |
| Functional | |||||||||||
| SIS—Recovery | 55.5 (16.4) | 64.8 (15.0) |
9.3 (14.3) p = 0.069 |
.57 | 45.0 (20.7) | 43.8 (21.3) |
− 1.2 (1.9) p = 0.201 |
0.05 | t = 2.291, p = 0.046 | ||
| NFI—Informant (Total) | 155.6 (38.1) | 138.0 (29.8) | 136.1 (37.3) |
− 17.6 (19.5) p = 0.107 |
.49 | ||||||
BBT Box and Block Test; LAH Less Affected Hand; MAH More Affected Hand; 9HPT Nine Hole Peg Test (pegs/s); MoCA Montreal Cognitive Assessment; SIS Stroke Impact Scale; NFI Neurobehavioral Functioning Inventory
aMean (SD)
bDependent-samples t-test comparing pre-test vs. post-test
cIndependent-samples t-test comparing EDNA vs. GRASP
dHedges’ g
*p < Benjamini–Hochberg critical value